NCT06235541 2025-07-17
A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors
Genome & Company
Phase 1 Withdrawn
Clinical Trials
7 trialsNCT06719973 2025-06-17
Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
EMD Serono
Phase 1 Withdrawn
NCT02462707 2015-10-07
A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors
Pfizer
Phase 1 Withdrawn
NCT00792558 2015-09-01
Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers
Bristol-Myers Squibb
Phase 1 Withdrawn
NCT00682279 2015-04-17
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Withdrawn
NCT01170871 2014-05-21
Ixabepilone and Pemetrexed/Solid Tumors
University of Southern California
Phase 1 Withdrawn
NCT01521299 2012-08-28
A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors
Dartmouth-Hitchcock Medical Center
Phase 1 Withdrawn